Carbiotix

Carbiotix

person lying on gray sofa

Carbiotix Signs JCDA with Global Beverage Leader

Sammanfattning

Carbiotix has signed a JCDA with a leading global beverage solutions provider, aiming to upcycle grain, fruit, and vegetable side-streams into valuable extracts.
Carbiotix announces a new JCDA with a global B2B beverage provider, opening new business opportunities.

Carbiotix, a pioneering biotechnology company, has once again made headlines with the announcement of a Joint Collaboration and Development Agreement (JCDA) with a global B2B beverage solutions provider. This new collaboration is set to open a plethora of business opportunities, allowing Carbiotix to expand its reach to numerous Food & Beverage Consumer Packaged Goods (F&B CPG) companies.

Under the leadership of CEO Erik Deaner, Carbiotix aims to leverage the JCDA partner's extensive operations, which span over 50 countries and include more than 10 manufacturing sites. These sites generate thousands of tons of grain, fruit, and vegetable-based side-streams, which Carbiotix plans to upcycle into extracts for human, pet-food, and feed applications.

The financial prospects are promising, with Carbiotix targeting an average revenue of 0.50 USD per kilogram of extract over the lifetime of multi-party licenses and operator agreements. This strategy not only presents value creation for side-stream owners but also offers a 50% discount for F&B CPG partners compared to market ingredients.

The JCDA is scheduled to commence in Q4 2025, with a six-month period for formulation verification and engineering specification development. The ultimate goal is to decide on constructing a NutraCycle process, enhancing the partner's ability to capture value from their side-streams.

Considering Carbiotix's innovative approach and strategic partnerships, investors may find the company's stock an attractive 'buy' option. The potential for growth and expansion into new markets, alongside their commitment to sustainability and health, positions Carbiotix as a promising player in the biotechnology sector.

Relaterade nyheter

Loading...